Dementia Alzheimers Clinical Trial
Official title:
Developing Immersive Gamification Technology Systems for the Management of Patients With Alzheimer's Disease With Behavioral and Psychological Symptoms of Dementia (Phase 2 Trial)
NCT number | NCT06072014 |
Other study ID # | AXEL0003 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | July 10, 2023 |
Est. completion date | December 2023 |
The proposed research project aims to answer the question "Are immersive technology systems effective in the management and treatment of patients with BPSD?". This project is composed of three phases and the current study is the second phase. The phase 2 trial aims to create an immersive technology system for managing the behavioral and psychological symptoms of dementia and determine its clinical effectiveness, safety, usability, and acceptability among patients with mild to moderate Alzheimer's disease.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | December 2023 |
Est. primary completion date | December 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility | Inclusion Criteria: - Aged 60 years old or older - Diagnosed with mild to moderate Alzheimer's dementia according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria - Montreal Cognitive Assessment-Philippines (MOCA-P) score of 10-20 inclusive - Neuropsychiatric Inventory (NPI-12) score 1-50 inclusive - Reisberg Scale Stage 4-5 inclusive - Stable dose of antidepressants for the past 6 weeks - Stable dose of antipsychotics for the past 4 weeks - Able to walk unassisted or with minimal assistance, with or without assistive device - No other explanation for condition based on reasonable clinical diagnostics Exclusion Criteria: - Have mild cognitive impairment (no dementia) - Have MOCA-P score less than 10 or more than 20 - Other non-amnestic dementia syndromes - Have receptive aphasia - Have significant visual or hearing impairment - Have an active psychiatric disorder prior to Alzheimer dementia diagnosis - Had previous episodes of seizures, diagnosis of epilepsy, or intake of antiepileptic or seizure medications - Have quadriplegia or paralysis of the dominant hand - Have a history of motion sickness - Experience claustrophobia - Have a diagnosis of a terminal illness or a life expectancy of less than one year |
Country | Name | City | State |
---|---|---|---|
Philippines | University of the Philippines College of Allied Medical Professions Immersive Technology Laboratory | City Of Manila | National Capital Region |
Lead Sponsor | Collaborator |
---|---|
Augmented eXperience E-health Laboratory |
Philippines,
Anlacan, V.M.M. et al. (2023). Application Design for a Virtual Reality Therapy Game for Patients with Behavioral and Psychological Symptoms of Dementia. In: Krouska, A., Troussas, C., Caro, J. (eds) Novel & Intelligent Digital Systems: Proceedings of the 2nd International Conference (NiDS 2022). NiDS 2022. Lecture Notes in Networks and Systems, vol 556. Springer, Cham. https://doi.org/10.1007/978-3-031-17601-2_15
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Acceptability | Acceptability will be measured among a small group of patients and their caregivers through an interview and a focus group discussion | Within one day after completing virtual reality experience | |
Primary | Incidence of behavioral and psychological symptoms of dementia will be assessed using the Neuropsychiatric Inventory-12 | The NPI evaluates the degree and severity of BPSDs and the distress it causes the primary caregiver. Scores range from 0 to 120 where higher scores indicate greater psychiatric disturbance. | Within one hour after completion of the fourth session | |
Primary | Incidence of virtual reality sickness symptoms will be assessed using the Virtual Reality Sickness Questionnaire | The VRSQ will measure a participant's experience with the following symptoms: general discomfort, fatigue, eye strain, difficulty focusing, headache, fullness of head, blurring of vision, dizziness (when eyes are closed), and vertigo. Symptoms will be rated on a 4-point scale: 0 or None, 1 or Slight, 2 or Moderate, and 3 or Severe. | Immediately after each intervention, within an hour of completion of the virtual reality game | |
Primary | Usability of the virtual reality intervention will be assessed using the System Usability Scale | The SUS is a 10-item questionnaire that is widely used in the evaluation of various kinds and aspects of technology. Each question has five response options ranging from 'Strongly agree' to 'Strongly disagree', which has a corresponding number value. Each response is added and multiplied by 2.5 to obtain the final score that ranges from 0 to 100. A SUS score above 68 is considered above average. | Immediately after each intervention, within an hour of completion of the virtual reality game | |
Secondary | Cognitive function will be assessed using MOCA-P | Montreal Cognitive Assessment-Philippines (MOCA-P) is a 30-item test that takes about 10-12 minutes to complete. The test measures different cognitive domains such as visuospatial/executive, naming, memory, attention, language, abstraction, and orientation. | Within one hour after completion of the fourth session | |
Secondary | Cognitive function will be assessed using MMSE | The Mini-Mental State Exam (MMSE) is a 30-item test for cognitive function. It assesses attention, orientation, memory, registration, recall, calculation, language, and an individual's ability to draw a complex polygon. | Within one hour after completion of the fourth session | |
Secondary | Cognitive function will be assessed using ADAS-Cog | The cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog) is an 11-item tool for the assessment of the following tasks: word recall, naming objects and fingers, commands, constructional praxis, ideational praxis, orientation, word recognition, and language. | Within one hour after completion of the fourth session | |
Secondary | Activities of daily living will be assessed using ADCS-ADL | The Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL) is a 24-item assessment on activities of daily living within the past four weeks | Within one hour after completion of the fourth session | |
Secondary | Health-related quality of life will be assessed using DEMQOL | The Health-related quality of life for people with dementia (DEMQOL) is a 28-item self-report measure of quality of life specific for persons with mild-to-moderate dementia. It covers four dimensions of quality of life, namely, daily activities, memory, negative emotion, and positive emotion. | Within one hour after completion of the fourth session |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT03378245 -
Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations
|
N/A | |
Recruiting |
NCT04871698 -
On Site Sensors Monitoring Impacts of Cognitive Decline on ADLs
|
||
Active, not recruiting |
NCT05847153 -
MASC: Reducing Stress for Caregivers
|
N/A | |
Recruiting |
NCT04863859 -
Persons With Dementia and Their Extended Family Caregivers
|
||
Active, not recruiting |
NCT05529277 -
Implementing Dementia Care Management Into Routine Care in the Region Siegen-Wittgenstein
|
||
Active, not recruiting |
NCT03631069 -
Detecting Dementia in the Retina Using Optical Coherence Tomography
|
||
Not yet recruiting |
NCT06047340 -
Feasibility Study of Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
N/A | |
Terminated |
NCT03682874 -
Identifying Novel Aging Targets for Treatment of Delirium
|
||
Completed |
NCT03907748 -
Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia
|
N/A | |
Completed |
NCT04058886 -
Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers
|
N/A | |
Not yet recruiting |
NCT05606445 -
Surface EMG to Measure Paratonia in Dementia
|
||
Recruiting |
NCT04308512 -
Care Coordination System for People With Dementia
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03943641 -
Dementia Risk Prediction Model: Development and Validation
|
||
Not yet recruiting |
NCT05245903 -
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
|
||
Not yet recruiting |
NCT06396377 -
Interest of the Reborn® Doll as a TO in the Care of Residents With Alzheimer's Disease or a Related Disorder
|
N/A | |
Recruiting |
NCT03472482 -
Optical Coherence Tomography in Cerebral Amyloidosis
|
||
Recruiting |
NCT04313582 -
Feasibility of the SmartPrompt for Improving Everyday Function in Dementia
|
N/A | |
Recruiting |
NCT05315895 -
The Dampness Syndrome of Chinese Medicine Cohort Study
|
||
Completed |
NCT04462029 -
A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers
|
Early Phase 1 |